Literature DB >> 30245177

Global Unmet Needs in Cardiac Surgery.

Peter Zilla1, Magdi Yacoub2, Liesl Zühlke3, Friedhelm Beyersdorf4, Karen Sliwa5, Gennadiy Khubulava6, Abdelmalek Bouzid7, Ana Olga Mocumbi8, Devagourou Velayoudam9, Devi Shetty10, Chima Ofoegbu11, Agneta Geldenhuys12, Johan Brink11, Jacques Scherman11, Henning du Toit13, Saeid Hosseini14, Hao Zhang15, Xin-Jin Luo15, Wei Wang15, Juan Mejia16, Theodoros Kofidis17, Robert S D Higgins18, Jose Pomar19, R Morton Bolman20, Bongani M Mayosi21, Rajhmun Madansein22, Joseph Bavaria23, Alberto A Yanes-Quintana24, A Sampath Kumar9, Oladapo Adeoye25, Risenga Frank Chauke26, David F Williams27.   

Abstract

More than 6 billion people live outside industrialized countries and have insufficient access to cardiac surgery. Given the recently confirmed high prevailing mortality for rheumatic heart disease in many of these countries together with increasing numbers of patients needing interventions for lifestyle diseases due to an accelerating epidemiological transition, a significant need for cardiac surgery could be assumed. Yet, need estimates were largely based on extrapolated screening studies while true service levels remained unknown. A multi-author effort representing 16 high-, middle-, and low-income countries was undertaken to narrow the need assessment for cardiac surgery including rheumatic and lifestyle cardiac diseases as well as congenital heart disease on the basis of existing data deduction. Actual levels of cardiac surgery were determined in each of these countries on the basis of questionnaires, national databases, or annual reports of national societies. Need estimates range from 200 operations per million in low-income countries that are nonendemic for rheumatic heart disease to >1,000 operations per million in high-income countries representing the end of the epidemiological transition. Actually provided levels of cardiac surgery range from 0.5 per million in the assessed low- and lower-middle income countries (average 107 ± 113 per million; representing a population of 1.6 billion) to 500 in the upper-middle-income countries (average 270 ± 163 per million representing a population of 1.9 billion). By combining need estimates with the assessment of de facto provided levels of cardiac surgery, it emerged that a significant degree of underdelivery of often lifesaving open heart surgery does not only prevail in low-income countries but is also disturbingly high in middle-income countries.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30245177     DOI: 10.1016/j.gheart.2018.08.002

Source DB:  PubMed          Journal:  Glob Heart        ISSN: 2211-8160


  21 in total

Review 1.  Rheumatic heart disease: current status of diagnosis and therapy.

Authors:  Ferande Peters; Ganesan Karthikeyan; Jessica Abrams; Lorrein Muhwava; Liesl Zühlke
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 2.  A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICs).

Authors:  Peter Zilla; R Morton Bolman; Percy Boateng; Karen Sliwa
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

3.  Performance of a Risk Analytic Tool (Index of Tissue Oxygen Delivery "IDO2") in Pediatric Cardiac Intensive Care Unit of a Developing Country.

Authors:  Qalab Abbas; Muhammad Zaid H Hussain; Fatima Farrukh Shahbaz; Naveed Ur Rehman Siddiqui; Babar S Hasan
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

4.  The effects of remifentanil combined with propofol on the oxidative damage and the stress and inflammatory responses in cardiac surgery patients.

Authors:  Xiaojing Li; Hongxia Xiang; Wen Zhang; Chunling Peng
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 5.  Endomyocardial Fibrosis: an Update After 70 Years.

Authors:  Ana Olga Mocumbi; J Russell Stothard; Paulo Correia-de-Sá; Magdi Yacoub
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

6.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic Stenosis.

Authors:  Amgad Mentias; Marwan Saad; Milind Y Desai; Amar Krishnaswamy; Venu Menon; Phillip A Horwitz; Samir Kapadia; Mary Vaughan Sarrazin
Journal:  J Am Coll Cardiol       Date:  2021-04-13       Impact factor: 24.094

7.  Patient characteristics and cardiac surgical outcomes at a tertiary care hospital in Kenya, 2008-2017: a retrospective study.

Authors:  Tamara Chavez-Lindell; Agricola Odoi; Bob Kikwe; Anthony Gikonyo
Journal:  PeerJ       Date:  2021-05-10       Impact factor: 2.984

8.  Clinical outcomes of children with rheumatic heart disease.

Authors:  Meghan Zimmerman; Samalie Kitooleko; Emmy Okello; Nicholas Ollberding; Pranava Sinha; Tom Mwambu; Craig Sable; Andrea Beaton; Chris Longenecker; Peter Lwabi
Journal:  Heart       Date:  2022-02-02       Impact factor: 7.365

Review 9.  Congenital Heart Disease in Low- and Lower-Middle-Income Countries: Current Status and New Opportunities.

Authors:  Liesl Zühlke; John Lawrenson; George Comitis; Rik De Decker; Andre Brooks; Barend Fourie; Lenise Swanson; Christopher Hugo-Hamman
Journal:  Curr Cardiol Rep       Date:  2019-11-29       Impact factor: 2.931

10.  Health system costs of rheumatic heart disease care in South Africa.

Authors:  Assegid G Hellebo; Liesl J Zuhlke; David A Watkins; Olufunke Alaba
Journal:  BMC Public Health       Date:  2021-07-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.